Advanced Medicine Partners is driven to accelerate the development of innovative advanced medicines to enable partnering companies to make a positive difference for the patients they serve. With one of the most experienced genetic medicines teams in the industry - at all levels, from bench to boardroom - the company uses its expertise to produce best-in-class advanced therapy products and analytics with a specialty in viral vectors for gene and cell therapies. Advanced Medicine Partners' exclusive manufacturing platform consistently produces yields that are among the highest in the industry and purity profiles that continue to push the boundaries of what's possible.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/05/24 | $32,000,000 |
ARCH Venture Partners Deerfield Management Company, L.P.  | undisclosed |
